-
Teen birth rates in the United States are dropping sharply, especially among Hispanic teens, according to a new government report.Full Story > Teen birth rates in the United States are dropping sharply, especially among Hispanic teens, according to a new government report.Full Story > The overall health of Americans isn't improving much, with about six in 10 people either overweight or obese and large numbers engaging in unhealthy behaviors like smoking, heavy drinking or not exercising.Full Story > The overall health of Americans isn't improving much, with about six in 10 people either overweight or obese and large numbers engaging in unhealthy behaviors like smoking, heavy drinking or not exercising.Full Story > When a classmate commits suicide, teens are more likely to consider or attempt suicide themselves, according to a new study. Full Story > When a classmate commits suicide, teens are more likely to consider or attempt suicide themselves, according to a new study. Full Story > Pregnant women with specific alterations in two genes may be at increased risk of suffering depression after giving birth, a small new study suggests.Full Story > Pregnant women with specific alterations in two genes may be at increased risk of suffering depression after giving birth, a small new study suggests.Full Story > Although spring arrived late this year in parts of the United States, the summer allergy season will still be strong, according to a sinus expert at the University of Alabama at Birmingham.Full Story > Although spring arrived late this year in parts of the United States, the summer allergy season will still be strong, according to a sinus expert at the University of Alabama at Birmingham.Full Story >
-
Heavy consumption of diet soda can damage teeth as badly as methamphetamine or crack cocaine, a new study contends.Full Story > Heavy consumption of diet soda can damage teeth as badly as methamphetamine or crack cocaine, a new study contends.Full Story > Teen birth rates in the United States are dropping sharply, especially among Hispanic teens, according to a new government report.Full Story > Teen birth rates in the United States are dropping sharply, especially among Hispanic teens, according to a new government report.Full Story > Kids who eat fast food at least twice a week are 50 percent less likely to use calorie and nutritional information than kids who eat fast food less often.Full Story > Kids who eat fast food at least twice a week are 50 percent less likely to use calorie and nutritional information than kids who eat fast food less often.Full Story > The American Cancer Society, which is celebrating on Wednesday a century of fighting a disease once viewed as a death sentence, is making a pledge to put itself out of business.Full Story > The American Cancer Society, which is celebrating on Wednesday a century of fighting a disease once viewed as a death sentence, is making a pledge to put itself out of business.Full Story > In the aftermath of this week's deadly tornado, many people in Oklahoma are not only struggling to care for children and relatives, but also their pets.Full Story > In the aftermath of this week's deadly tornado, many people in Oklahoma are not only struggling to care for children and relatives, but also their pets.Full Story >
Information contained on this page is provided by companies via press release distributed through PR Newswire, an independent third-party content provider. PR Newswire, WorldNow and this Station make no warranties or representations in connection therewith.
SOURCE Orexigen Therapeutics, Inc.
SAN DIEGO, Feb. 28, 2013 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will present a company overview at the Cowen & Co. Annual Health Care Conference in Boston. The presentation is scheduled for Monday, March 4, 2013 at 3:30 p.m. Eastern Time. To listen to the live webcast or a replay of the presentation, please visit the Investor Relations section of the Company's Web site at www.orexigen.com. A replay will be available for 14 days after the event.
About Orexigen® Therapeutics
Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. The Company's lead product candidate is Contrave®, which has completed Phase III clinical trials and for which a New Drug Application has been submitted and reviewed by the FDA. The Company has also reached agreement with the FDA on a Special Protocol Assessment for the Light Study, the Contrave cardiovascular outcomes trial. The Company's other product candidate, Empatic™, has completed Phase II clinical trials. Further information about the Company can be found at www.orexigen.com.
|
Orexigen Contact:
|
Media Contact:
|
|
McDavid Stilwell
|
Denise Powell
|
|
VP, Corporate Communications and Business Development
|
WCG
|
|
(858) 875-8629
|
(510) 703-9491
|
©2012 PR Newswire. All Rights Reserved.
FOX19-WXIX
